Arbutamine
Genesa (arbutamine) is a small molecule pharmaceutical. Arbutamine was first approved as Genesa on 1997-09-12.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Arbutamine hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| GENESA | Gensia Automedics | N-020420 DISCN | 1997-09-12 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| J0395 | Injection, arbutamine hcl, 1 mg |
Clinical
Clinical Trials
42 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 14 | 14 | 5 | 3 | 33 |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | — | — | 1 | — | 1 |
| Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Consciousness disorders | D003244 | — | 2 | 1 | — | — | 2 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hallucinations | D006212 | HP_0000738 | F06.0 | — | 1 | — | — | — | 1 |
| Brain injuries | D001930 | S06.9 | — | 1 | — | — | — | 1 | |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Progressive supranuclear palsy | D013494 | EFO_0002512 | G23.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | ARBUTAMINE |
| INN | arbutamine |
| Description | Arbutamine is a catecholamine. It has a role as a beta-adrenergic agonist and a cardiotonic drug. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | Oc1ccc(CCCCNC[C@H](O)c2ccc(O)c(O)c2)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 128470-16-6 |
| RxCUI | 61609 |
| ChEMBL ID | CHEMBL1201251 |
| ChEBI ID | 50580 |
| PubChem CID | 60789 |
| DrugBank | DB01102 |
| UNII ID | B07L15YAEV (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 599 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,016 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more